Published in Medical Devices and Surgical Technology Week, June 22nd, 2008
"A morpholino targeted to Psf2 mRNA was designed to knockdown Psf2 translation and was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.